(Medical Xpress)—On April 15, the Supreme Court will hear oral argument in Association for Molecular Pathology v. Myriad Genetics, a case that could answer the question, "Under what conditions, if any, are isolated human ...
Apr 11, 2013
14
0
Humans don't "own" their own genes, the cellular chemicals that define who they are and what diseases they might be at risk for. Through more than 40,000 patents on DNA molecules, companies have essentially claimed the entire ...
Mar 26, 2013
15
0
Rapid advances in genetic disease research that are transforming how we diagnose and treat illness require new safeguards to protect patients from the misuse of these technologies and realize their full potential, according ...
May 30, 2012
0
0
Today, the Association for Molecular Pathology (AMP) asked the U.S. Patent and Trademark Office (USPTO) to place a moratorium on the issuing of patents on human genes during testimony presented at an Agency hearing on genetic ...
Feb 16, 2012
0
0
St. Michael's Hospital and King Saud University have received their first joint U.S. patent to use the BRCA1 gene as a therapy for cardiovascular disease.
Feb 10, 2012
0
0
The American Civil Liberties Union and the Public Patent Foundation have petitioned the U.S. Supreme Court to hear Association for Molecular Pathology v. U.S. Patent and Trademark Office, a case that challenges the validity ...
Dec 15, 2011
0
0
VTT Ventures Oy has established a spin-off which develops next-generation allergy vaccines. The spin-off is called Desentum Oy, and its operations are based on a VTT patented technology. Years of research, testing and official ...
Oct 21, 2011
0
0
A federal appeals court on Friday ruled in favor of Myriad Genetics after a legal battle over whether the US company could keep its patent on genes linked to an inherited form of breast cancer.
Jul 30, 2011
1
0
